Literature DB >> 27002094

Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study.

Doff B McElhinney1, Michael D Quartermain1, Damien Kenny1, Ernerio Alboliras1, Zahid Amin2.   

Abstract

BACKGROUND: Transcatheter closure of secundum atrial septal defects (ASD) using the Amplatzer septal occluder is generally safe and effective, but erosion into the pericardial space or aorta has been described. Although the absolute risk of this complication is low, there has been no assessment of relative risk factors. METHODS AND
RESULTS: All erosions reported to St. Jude Medical after ASD closure with an Amplatzer septal occluder (cases) were compared with controls (matched 2:1) who underwent ASD closure but did not develop an erosion. A total of 125 erosions were reported between 2002 and 2014, including 95 with an available echocardiogram. The median duration from implant to erosion was 14 days, but was >1 year in 16 patients. Nine patients (all age ≥17 years) who died were more likely to have an oversized device, and to have erosion into the aorta, than survivors. Aortic or superior vena cava rim deficiencies were more common in cases than in controls. In addition, larger balloon-sized ASD diameter, Amplatzer septal occluder device size, and device size-ASD diameter difference, and smaller weight:device size ratio were associated with erosion. On multivariable analysis, deficiency of any rim, device >5 mm larger than ASD diameter, and weight:device size ratio were associated with erosion.
CONCLUSIONS: In addition to aortic rim deficiency, which was almost universal among erosion cases, there were several relative risk factors for erosion after ASD closure with the Amplatzer septal occluder device. To understand the mechanisms of and absolute risk factors for this uncommon but serious complication, an adequately powered prospective study with thorough echocardiographic evaluation will be critical.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  amplatzer septal occluder; cardiac tamponade; echocardiography; erosion; heart diseases; vascular closure devices

Mesh:

Year:  2016        PMID: 27002094     DOI: 10.1161/CIRCULATIONAHA.115.019987

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  A life-saving case of cardiopulmonary arrest with cardiac tamponade caused by erosion 6 years after percutaneous atrial septal defect closure: a case report.

Authors:  Takuma Kobayashi; Taiji Watanabe; Haruka Fu; Okada Yohei; Tomoyuki Goto
Journal:  J Cardiothorac Surg       Date:  2021-05-21       Impact factor: 1.637

2.  Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years.

Authors:  Jan-Erik Guelker; Ruben Jansen; Kolja Sievert; Horst Sievert; Stefan Bertog
Journal:  Clin Res Cardiol       Date:  2018-02-26       Impact factor: 5.460

3.  How to Size ASDs for Percutaneous Closure.

Authors:  Isabelle Boon; Katrien Vertongen; Bernard P Paelinck; Laurent Demulier; An Van Berendoncks; Catherine De Maeyer; Fabienne Marchau; Joseph Panzer; Kristof Vandekerckhove; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2017-09-27       Impact factor: 1.655

Review 4.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

Review 5.  ASD Closure in Structural Heart Disease.

Authors:  Dominik M Wiktor; John D Carroll
Journal:  Curr Cardiol Rep       Date:  2018-04-17       Impact factor: 2.931

6.  Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.

Authors:  Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2017-07-19       Impact factor: 4.749

Review 7.  Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.

Authors:  Michael L O'Byrne; Andrew C Glatz; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

Review 8.  Transcatheter closure of atrial septal defect: principles and available devices.

Authors:  Se Yong Jung; Jae Young Choi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 9.  Atrial septal defect closure: indications and contra-indications.

Authors:  Alain Fraisse; Monica Latchman; Shiv-Raj Sharma; Selin Bayburt; Pascal Amedro; Giovanni di Salvo; Alban Elouen Baruteau
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 10.  Atrial septal defect (ASD) device trans-catheter closure: limitations.

Authors:  Alessia Faccini; Gianfranco Butera
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.